Cellular constituents of the alveolar-capillary wall may be key participants in the recruitment of polymorphonuclear leukocytes to the lung through the generation of the novel neutrophil chemotactic peptide interleukin-8 (IL-8 Invest. 1990Invest. . 86:1945Invest. -1953
Sequestration of polymorphonuclear leukocytes (PMN)'
within the lung is characteristic of a number of acute and chronic pulmonary diseases (1) (2) (3) . The presence of PMNs is determined by the local generation of chemotactic agents, which direct PMN migration from the vascular compartment to the alveolar space along established chemotactic gradients. Although an array of chemotactic factors have been isolated from the lung, none have shown leukocyte specificity (2, 4, 5) . Furthermore, the cellular origins of these chemoattractants have not been fully elucidated. Substantial investigation has focused on the human alveolar macrophage (AM) as a primary source of these chemotactic factors (6) (7) (8) . Recently, however, neutrophil chemotactic activity has been found to be produced by endothelial cells (9) , fibroblasts (10) , and pulmonary epithelial cells (11) (12) (13) . While the AM may be a principal cell in orchestrating the elicitation of PMN to the air space, other cellular constituents of the alveolar-capillary wall may participate in mediating this recruitment event. Recently, a polypeptide with specific neutrophil chemotactic activity, interleukin-8 (IL-8), has been cloned (14) and isolated from a number of cells including: peripheral blood monocytes (15, 16) , endothelial cells (9) , fibroblasts (10) , and synovial cells (17) . Stimulus specificity for the elaboration of this cytokine has been demonstrated using both exogenous and endogenous stimuli. Mononuclear phagocytes and endothelial cells have the ability to generate IL-8 in response to an exogenous stimulus such as lipopolysaccharide (LPS) . In contrast, a host-generated stimulus, such as tumor necrosis factor (TNF) or interleukin-I (IL-1), is required for the production of fibroblast and synovial cell-derived IL-8. This latter interaction is demonstrative of cytokine-networking, whereby one cell population is dependent upon mediators synthesized by a neighboring cell. This interaction may be exemplified in the lung where the alveolar space is in contact with the ambient environment, which may provide the exogenous stimulus (e.g., bacterial products) for AM-derived cytokines. These polypeptide mediators may then act in a paracrine fashion to stimulate nonimmune cellular components of the alveolar-capillary wall to produce additional effector molecules. In this study we demonstrate that stimulated pulmonary epithelial-like cells possess effector activity in the inflammatory process by generating IL-8. Furthermore, cellular communication between A549 pulmonary epithelial cells and AMs appear to operate via the generation of AM-derived TNF and IL-1, as these cytokines are essential for the production of epithelial cell-derived IL-8.
Methods
Reagent preparation. Human recombinant IL-la and IL-l# with a specific activity of 20 U/ng and 30 U/ng, respectively, and murine antihuman monoclonal IL 10 U of TNF at a dilution of 1:25,625, whereas 1 ,ug of the murine antihuman monoclonal IL-1,B antibody was capable of inhibiting 95% of the IL-1I -induced production of IL-2 by lA5 murine T cells. Efficacy of neutralizing antihuman IL-8 antibodies has been previously reported (10) . Serial dilutions of pyrogen free cytokines were prepared in RPMI 1640 (Whittaker Bio products, Walkersville, MD) containing 1 mM glutamine, 25 mM Hepes, 100 U/ml penicillin 100 ng/ml streptomycin (Hazleton Biologics, Inc., St. Lenexa, KS) (complete media). Stock LPS (E. coli 011 1 :B4, Sigma Chemical Co., St. Louis, MO) was prepared at a concentration of 200 ,g/ml in complete media.
Preparation ofA549 pulmonary epithelial cells. A549 pulmonary epithelial cells (American Type Culture Collection, Rockville, MD) are a cell line derived from a patient with alveolar cell carcinoma of the lung. These cells retain features of type II alveolar epithelial cells, including cytoplasmic multilamellar inclusion bodies and the synthesis of surfactant (18) . The A549 cell line was used in these studies since human type II cells are both difficult to obtain in pure culture and are often contaminated with resident mononuclear phagocytic cells. Human A549 pulmonary epithelial cells were grown to confluency on 100 mm petri dishes (Corning Glass Works, Corning, NY) in complete RPMI 1640, plus 10% FCS. On the day of use, A549 monolayers were washed free of FCS with complete media and either cytokines or LPS was added for the specified times and doses. Cell-free supernatants were collected, and total cellular RNA was extracted as described below.
Recovery and isolation ofhuman alveolar macrophages (AM) and generation ofconditioned media. Five normal, nonsmoking volunteers agreed to undergo flexible fiberoptic bronchoscopy with bronchoalveolar lavage (BAL) by standard techniques ( 19 Immunohistochemistry. Immunolocalization of IL-8 was performed by fixing A549 cell monolayers in 4% paraformaldehyde in PBS for 10 min, then rinsing twice with PBS. Before staining, the slides were treated for 15 min in 1:1 absolute methanol and 3% H202, rinsed in PBS then nonspecific binding sites were blocked with a 1:50 dilution of normal goat serum. Normal serum was removed, followed by the addition of 1:2,000 concentration of either control (rabbit) or rabbit antihuman IL-8 serum. After 15 min of incubation at 37°C, the slides were rinsed with PBS, overlaid with biotinylated goat antirabbit IgG (1:200; Vector Laboratories Inc., Burlingame, CA), incubated 15 min, and rinsed two times with PBS. The slides were treated with Streptavidin conjugated to peroxidase for 15 min at 37°C, rinsed three times, overlaid with substrate chromogen (3-amino 9-ethylcarbazole) for 7 min at 37°C to allow color development, and rinsed with distilled water. Mayer's hematoxylin was used as counterstain. To demonstrate antibody specificity, in competitive inhibition studies, immunostaining for human IL-8 showed 100% inhibition by the addition of exogenous recombinant IL-8.
Interleukin 8 ELISA. Antigenic IL-8 was quantitated using a double ligand method as previously described by Bacon et al. (23) . Briefly, flat-bottomed 96-well microtiter plates (Nunc Immuno-Plate I 96-F) were coated with immunosorbent purified goat anti-IL-8 antibody (0.5 Mg in 100 Ml 0.1 M NaHCO3/NaCO3 buffer, pH 9.6) for 16 h at 4°C and then washed four times with PBS, pH 7.5 with 0.5% Tween-20 (washing buffer). Samples and standards, both in duplicate, were added as 100-,ul aliquots in washing buffer containing 2% FCS and incubated for 90 min at 37°C. Plates were then washed four times and incubated with biotinylated goat anti-IL-8 antibody (25 ng per well) for 30 min at 37°C. Plates were washed four times and incubated with avidin-peroxidase conjugate (Bio-Rad Laboratories, Richmond, CA) for 30 min at 37°C. Plates were then washed four times and incubated with the peroxidase substrate (Bio-Rad Laboratories) at room temperature to the desired extinction, and the reaction terminated with 3% oxalic acid. Plates were read at 405 nm in an ELISA reader. Standards were 1/2 log dilutions of recombinant IL-8, from 100 ng to 30 pg per well. This ELISA method consistently detected IL-8 concentrations in a linear fashion > 300 pg/ml.
Chemotactic assay. Human neutrophils were prepared from peripheral blood by Ficoll-Hypaque density gradient centrifugation followed by sedimentation in 5% dextran in 0.9% saline (Sigma Chemical Co.). Neutrophils were separated from erythrocytes by hypotonic lysis and then suspended in HBSS with calcium/magnesium (Gibco, Grand Island, NY) at 2 X 106 cells/ml with > 95% viability by trypan blue exclusion. Chemotaxis was performed as previously described (10) . Briefly, 225 Ml of diluted (1:1) supernatant specimen, IO-7 M formylmethionyleucylphenylalanine (fMLP, Sigma Chemical Co.) or HBSS alone was placed in duplicate bottom wells of a blind-well chemotaxis chamber. A 3-,um pore size polycarbonate filter (polyvinylpyrrolidone-free, Nucleopore Corp., Pleasanton, CA) was placed in the assembly and 333 Ml of neutrophil suspension placed in each of the top wells. Chemotaxis chamber assemblies were incubated at 37°C in humidified 95% air and 5% CO2 for 1 h. The filters were removed, fixed in methanol, and stained with 2% toluidine blue (Sigma Chemical Co.). Neutrophils that had migrated through the bottom of the filter were counted in 10 high-power fields (1,000X). Chemotactic bioactivity was standardized to and expressed as the percent of the positive control (l0-7 fMLP). In neutralization studies, A549 24-h conditioned media was incubated with a 1:100 or 1:1,000 dilution ofeither control (rabbit preimmune serum) or neutralizing rabbit antihuman IL-8 antiserum for 30 min at 37°C and then assayed for chemotactic activity.
Statistical analysis. Data are expressed as means±SEM. Groups of data were evaluated by analysis of variance (ANOVA). Data that appeared statistically significant were compared by Student's t test for comparing the means of multiple groups, and considered significant if P values were < 0.05.
Results
A549 cell-derived chemotactic activity. Confluent A549 cell monolayers were stimulated at time 0 with either 20 ng/ml TNF, 20 ng/ml IL-13f, or 10 ug/ml LPS and assessed for the time-dependent generation of chemotactic activity. At specific time intervals, supernatants were harvested and analyzed for chemotactic bioactivity. As depicted in Fig. 1 , TNF-treated A549 cells yielded significant neutrophil chemotactic activity as early as 1 h posttreatment, plateauing by 8 h, with maximal neutrophil chemotactic activity seen at 24 h (64±4.2% fMLP control, n = 3). Likewise, IL-113-treated cells generated significant neutrophil chemotactic activity as early as 2 h, the production plateaued by 4 h, with maximal chemotactic activity observed at 24 h posttreatment (41.5±3.2% fMLP control). In contrast, LPS-stimulated A549 cells generated only modest chemotactic activity that was 26±2.3% fMLP control at 24 h. Neither TNF, IL-113, nor LPS were directly chemotactic for neutrophils in the chemotactic assays.
Time-dependent expression ofsteady-state IL-8 mRNA by A549 cells. To determine whether A549 epithelial cells expressed mRNA for IL-8, A549 cell monolayers were stimulated at time 0 with TNF (20 ng/ml), IL-1B (20 ng/ml), or LPS (10 ,g/ml), and at specific time intervals total RNA was extracted. As shown in Fig. 2, IL-113 shown in Fig. 3 , IL-lIa, IL-ll, and TNF-stimulated A549 cells expressed mRNA for IL-8 in a dose-dependent fashion. In each ofthree experiments, the threshold concentration causing the expression of steady-state IL-8 mRNA for IL-la, IL-1, and TNF was 0.02 ng/ml, 0.02 ng/ml, and 2 ng/ml, respectively. Maximal IL-8 mRNA expression was seen at concentrations of 20 ng/ml for TNF and IL-1 a, and 2 ng/ml of IL-1,B.
No further induction of IL-8 mRNA was seen at higher concentrations of these cytokines. In contrast, LPS in various concentrations (1 pg to 10 ,ug) failed to induce IL-8 gene expression by A549 cells.
Demonstration of extracellular and cell-associated IL-8
antigen. To confirm the presence of A549-derived extracellular IL-8 protein, epithelial cells were stimulated with TNF (20 ng/ml), IL-1I3 (20 ng/ml), or LPS (1 ug/ml) and A549-conditioned media assessed for antigenic IL-8 by ELISA at specific time intervals. Fig. 4 Inhibition of A549-derived chemotactic activity by rabbit anti-human IL-8 antibody. To determine the relative contribution of IL-8 to A549-derived neutrophil chemotactic activity, 24-h conditioned media was harvested from TNF, IL-1#, LPS-stimulated and unstimulated A549 cells and preincubated with control (rabbit preimmune serum) and polyclonal rabbit anti-human IL-8 antibody (Table I) with either preimmune or anti-human IL-8 antibody (1:1,000) did not significantly alter the chemotactic activity of unstimulated or LPS-stimulated A549 conditioned media as compared with control serum. In addition, these antibodies did not alter fMLP-induced chemotaxis. In contrast, the chemotactic activity of IL-l(-treated A549 conditioned media was reduced by 53% in the presence of anti-human IL-8 antibody (P < 0.001). TNF-stimulated A549-derived chemotactic activity was also significantly reduced by anti-human IL-8 antibody, but to a lesser extent (19% suppression, (P < 0.01). Also shown in Table I , anti-human IL-8 antisera treatment rtsulted in 49, 66, and 33% suppression of the neutrophil chemotactic activity induced by 1, 10, and 100 ng/ml of recombinant IL-8, respectively. When background chemotactic activity was subtracted, IL-8 neutralization was even more complete.
Induction ofA549 cell IL-8 gene expression by LPS-stimulated human AM-condition media. Previous work in our laboratory and others have demonstrated IL-1 a, IL-1f3, and TNF production by LPS-stimulated human AM (2, 19, 20) . To ascertain whether human alveolar macrophages could secrete a soluble factor(s) that would induce the gene expression of IL-8 from A549 epithelial cells, cell-free human AM-conditioned media (24 h LPS-stimulated or unstimulated) was incubated with A549 cell monolayers. As depicted in Fig. 5 media. To better define the relative contributions of the specific AM-derived monokines TNF and IL-1(3, neutralization studies were performed (n = 3). LPS-stimulated AM-conditioned media was preincubated for 30 min with appropriate control antisera and/or IgG. In addition, AM-conditioned media was treated with either murine antihuman IL-I p monoclonal antibody (75 ,ug/ml), rabbit antihuman TNF polyclonal antibody (1:100), or both antibodies in combination and then overlaid on A549 cell monolayers. Total RNA was extracted at 4 h. As shown in Fig. 6 , antihuman IL-1(3 or antihuman TNF antibodies alone, or in combination resulted in a 44±8%, 28±7%, and 83±4% reduction in steady-state IL-8 mRNA levels, respectively. In contrast, LPS-stimulated AM-conditioned media induced maximal A549 epithelial cell-derived IL-8 mRNA in the presence of control rabbit sera, control murine IgG, or both controls in combination (data not shown).
Discussion
The influx of neutrophils is a predominant finding in many forms of acute and chronic lung injury. Enhanced neutrophil chemotactic activity has been seen in the bronchoalveolar lavage fluid from patients with several diverse pulmonary disease states including ARDS (4), idiopathic pulmonary fibrosis (2), and asbestosis (5). The mechanism(s) by which neutrophils and other inflammatory cells are recruited to the lung remain unknown, although the local generation ofchemotactic factors is essential in the initiation and evolution of this process. A number of locally generated chemotactic substances include: bacterial peptide fMLP (24) , extracellular matrix components such as laminin (25) , elastin, and collagen fragments (26, 27) , and fibronectin (28) . In addition, the AM can secrete several inflammatory cell chemoattractants including LTB4 (29) , PDGF (30) , and PAF (6) . Furthermore, AMs can generate TNF and IL-I (19, 20) , monokines which have been shown to stimulate IL-8 production by several nonimmune cells, including human endothelial cells (9) and fibroblasts (10) . The pulmonary epithelium, an integral component of the alveolar-capillary wall, serves multiple functions in the lungs, including maintenance of barrier-to-solvent and solute fluxes (31) , synthesis of surfactant (32) , and the metabolism of xenobiotics (33) . In the setting of lung injury, however, the pulmonary epithelium has generally been considered a target of inflammatory cells rather than an active participant in the generation of an inflammatory response (34, 35) . Recently, it has been shown that bovine bronchial epithelial cells (1 1) and bleomycin-treated rat type II cells (12) can generate inflammatory cell chemoattractants. Additional studies by Suzuki et al. (13) have described a neutrophil chemotactic factor generated from lung giant cell carcinoma (LU65C) that has a similar molecular weight (10,000 D) and significant amino acid homology to IL-8. We now demonstrate that A549 pulmonary epithelial cells generate chemotactic activity for neutrophils in the presence of specific monokines.
We have demonstrated the pulmonary epithelial cell-derived gene expression of IL-8 by Northern blot analysis, the production of chemotactic activity by bioassay, and the presence of antigenic extracellular and cell-associated IL- 8 derived TNF and IL-1,B. These findings establish direct cellto-cell communication between alveolar macrophages and pulmonary epithelial cells via the generation of these soluble mediators.
IL-8 is a recently described peptide that has been referred to as monocyte-derived neutrophil chemotactic factor (MDNCF) (15) , neutrophil-activating peptide-1 (NAP-1) (14) , neutrophil chemotactic factor (NCF) (9) , and most recently . In addition to being a potent neutrophil chemoattractant, IL-8 also stimulates neutrophil oxygen radical generation, degranulation (36) , and leukotriene synthesis (37) . The active form of IL-8 is a 72-amino acid peptide with an estimated molecular weight of 8,000 D, and belongs to a unique supergene family that includes murine macrophage inflammatory peptide-2, platelet factor 4, human platelet basic protein, human inducible protein IP-10, 9E3/pCEF-4 from Rous sarcoma transformed fibroblasts, and Gro (38 (40, 41) . These proteins in either a native or cleaved state can function as neutrophil chemoattractants. In addition, pulmonary epithelial cell-derived arachidonic acid has been shown to be metabolized by AM to the potent chemoattractant LTB4 (42) . Thus, redundancy exists in the pulmonary system in regard to the recruitment of immune cells.
Our findings suggest that pulmonary epithelial cells and potentially other cellular components of the alveolar-capillary wall can participate in the recruitment of inflammatory cells to the lungs through the generation of IL-8. The alveolar macrophage would appear to play a central role in the directed migration of neutrophils to the lung by responding to a primary signal (e.g., LPS) which leads to the elaboration ofchemotactic factors and subsequent neutrophil influx. In addition, the local generation of TNF and IL-I by the AM can act in a classical paracrine fashion to induce the expression of IL-8 by the surrounding nonimmune cells. This interaction would result in the directed diapedesis of PMNs from the vascular space into the interstitium and eventually into the alveolar spaces. Future investigations will undoubtedly establish the role(s) of IL-8 in the pathogenesis of ARDS, sarcoidosis, pulmonary fibrosis, and other pulmonary inflammatory disease states.
